248 related articles for article (PubMed ID: 35138140)
1. Differential Growth Rates and
Russell AC; Kyle DE
Microbiol Spectr; 2022 Feb; 10(1):e0189921. PubMed ID: 35138140
[TBL] [Abstract][Full Text] [Related]
2. The anti-amoebic activity of Pinus densiflora leaf extract against the brain-eating amoeba Naegleria fowleri.
Lê HG; Kim W; Kang JM; Võ TC; Yoo WG; Cheong H; Na BK
Parasites Hosts Dis; 2024 May; 62(2):169-179. PubMed ID: 38835258
[TBL] [Abstract][Full Text] [Related]
3. Comparative Genomic and Transcriptomic Analysis of Naegleria fowleri Clinical and Environmental Isolates.
Joseph SJ; Park S; Kelley A; Roy S; Cope JR; Ali IKM
mSphere; 2021 Aug; 6(4):e0063721. PubMed ID: 34378985
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic Screens Reveal Posaconazole as a Rapidly Acting Amebicidal Combination Partner for Treatment of Primary Amoebic Meningoencephalitis.
Colon BL; Rice CA; Guy RK; Kyle DE
J Infect Dis; 2019 Mar; 219(7):1095-1103. PubMed ID: 30358879
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic chokepoints and synergistic drug targets in the sterol biosynthesis pathway of Naegleria fowleri.
Zhou W; Debnath A; Jennings G; Hahn HJ; Vanderloop BH; Chaudhuri M; Nes WD; Podust LM
PLoS Pathog; 2018 Sep; 14(9):e1007245. PubMed ID: 30212566
[TBL] [Abstract][Full Text] [Related]
6. EdU Incorporation To Assess Cell Proliferation and Drug Susceptibility in Naegleria fowleri.
Troth EV; Kyle DE
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0001721. PubMed ID: 33846135
[TBL] [Abstract][Full Text] [Related]
7. Primary Amoebic Meningoencephalitis by
Güémez A; García E
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572533
[No Abstract] [Full Text] [Related]
8. Drug discovery for primary amebic meningoencephalitis: from screen to identification of leads.
Debnath A
Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1099-1106. PubMed ID: 33496193
[No Abstract] [Full Text] [Related]
9. Bis-benzimidazole hits against Naegleria fowleri discovered with new high-throughput screens.
Rice CA; Colon BL; Alp M; Göker H; Boykin DW; Kyle DE
Antimicrob Agents Chemother; 2015 Apr; 59(4):2037-44. PubMed ID: 25605363
[TBL] [Abstract][Full Text] [Related]
10. Identification of cysteine protease inhibitors as new drug leads against Naegleria fowleri.
Zyserman I; Mondal D; Sarabia F; McKerrow JH; Roush WR; Debnath A
Exp Parasitol; 2018 May; 188():36-41. PubMed ID: 29551628
[TBL] [Abstract][Full Text] [Related]
11. Corifungin, a new drug lead against Naegleria, identified from a high-throughput screen.
Debnath A; Tunac JB; Galindo-Gómez S; Silva-Olivares A; Shibayama M; McKerrow JH
Antimicrob Agents Chemother; 2012 Nov; 56(11):5450-7. PubMed ID: 22869574
[TBL] [Abstract][Full Text] [Related]
12. Naegleria fowleri: Sources of infection, pathophysiology, diagnosis, and management; a review.
Jahangeer M; Mahmood Z; Munir N; Waraich UE; Tahir IM; Akram M; Ali Shah SM; Zulfqar A; Zainab R
Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):199-212. PubMed ID: 31612525
[TBL] [Abstract][Full Text] [Related]
13. Naegleria fowleri: pathogenesis, diagnosis, and treatment options.
Grace E; Asbill S; Virga K
Antimicrob Agents Chemother; 2015 Nov; 59(11):6677-81. PubMed ID: 26259797
[TBL] [Abstract][Full Text] [Related]
14. Flucofuron as a Promising Therapeutic Agent against Brain-Eating Amoeba.
Chao-Pellicer J; Arberas-Jiménez I; Sifaoui I; Piñero JE; Lorenzo-Morales J
ACS Infect Dis; 2024 Jun; 10(6):2063-2073. PubMed ID: 38757533
[TBL] [Abstract][Full Text] [Related]
15. Amphotericin B induces apoptosis-like programmed cell death in Naegleria fowleri and Naegleria gruberi.
Cárdenas-Zúñiga R; Silva-Olivares A; Villalba-Magdaleno JA; Sánchez-Monroy V; Serrano-Luna J; Shibayama M
Microbiology (Reading); 2017 Jul; 163(7):940-949. PubMed ID: 28721850
[TBL] [Abstract][Full Text] [Related]
16. Identification and significance of Naegleria fowleri isolated from the hot spring which related to the first primary amebic meningoencephalitis (PAM) patient in Taiwan.
Tung MC; Hsu BM; Tao CW; Lin WC; Tsai HF; Ji DD; Shen SM; Chen JS; Shih FC; Huang YL
Int J Parasitol; 2013 Aug; 43(9):691-6. PubMed ID: 23665128
[TBL] [Abstract][Full Text] [Related]
17. CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM).
Debnath A; Calvet CM; Jennings G; Zhou W; Aksenov A; Luth MR; Abagyan R; Nes WD; McKerrow JH; Podust LM
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006104. PubMed ID: 29284029
[TBL] [Abstract][Full Text] [Related]
18. trans-Cinnamic Acid Conjugated Gold Nanoparticles as Potent Therapeutics against Brain-Eating Amoeba Naegleria fowleri.
Rajendran K; Anwar A; Khan NA; Shah MR; Siddiqui R
ACS Chem Neurosci; 2019 Jun; 10(6):2692-2696. PubMed ID: 30970208
[TBL] [Abstract][Full Text] [Related]
19. Identification and molecular typing of Naegleria fowleri from a patient with primary amebic meningoencephalitis in China.
Zhang LL; Wu M; Hu BC; Chen HL; Pan JR; Ruan W; Yao LN
Int J Infect Dis; 2018 Jul; 72():28-33. PubMed ID: 29751112
[TBL] [Abstract][Full Text] [Related]
20. Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
Kim JH; Jung SY; Lee YJ; Song KJ; Kwon D; Kim K; Park S; Im KI; Shin HJ
Antimicrob Agents Chemother; 2008 Nov; 52(11):4010-6. PubMed ID: 18765686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
